AI-generated summary
The authors report a split-mouth randomized trial in 10 adults with 40 maxillary implants in low-density bone, comparing 940-nm diode laser photobiomodulation with untreated control sites. They found higher implant stability at 2 months in treated sites, with no significant difference at 3 months, and no adverse effects were observed.
- Participants
- 10
- Who or what was studied
- Medically healthy adults requiring bilateral maxillary implants in D3-D4 low-density bone (10 participants, 40 implants)
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The abstract describes a small sample of 10 participants and a difference that was not significant at 3 months, with the primary analysis based on a mixed-effects model and a complete-case analysis used as support.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on quintessence-publishing.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.